Filing Details

Accession Number:
0000899243-16-023278
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2016-06-20 16:08:28
Reporting Period:
2016-06-15
Filing Date:
2016-06-20
Accepted Time:
2016-06-20 16:08:28
Original Submission Date:
2016-06-17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1042418 Hedgepath Pharmaceuticals Inc. HPPI Services-Commercial Physical & Biological Research (8731) 541641133
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1066040 Jr E Francis Odonnell 324 S. Hyde Park Avenue, Suite 350
Tampa FL 33606
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.0001 Par Value Per Share Acquisiton 2016-06-15 2,560,000 $0.00 16,560,000 No 4 P Indirect By Hopkins Capital Group II, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Hopkins Capital Group II, LLC
Footnotes
  1. On June 15, 2016, Hedgepath LLC transferred 2,560,000 shares of common stock to Hopkins Capital Group II, LLC ("HCGII") in satisfaction of $192,000 in then outstanding debt. This amendment to Form 4 is being filed by the Reporting Person to correctly reflect that the shares were transferred to HCGII and not transferred by HCGII to a third party.
  2. The shares are owned by HCGII. The Reporting Person is a discretionary beneficiary of an irrevocable spendthrift trust which directly owns a minority membership interest in HCGII. The Reporting Person disclaims ownership of all securities held by HCGII.